Cellectis S.A. (EPA:ALCLS)
France flag France · Delayed Price · Currency is EUR
3.570
+0.022 (0.62%)
May 14, 2026, 5:35 PM CET

Cellectis Revenue

Cellectis had revenue of $7.55M USD in the quarter ending March 31, 2026, a decrease of -37.25%. This brings the company's revenue in the last twelve months to $75.11M, up 37.20% year-over-year. In the year 2025, Cellectis had annual revenue of $79.59M with 61.72% growth.

Revenue (ttm)
$75.11M
Revenue Growth
+37.20%
P/S Ratio
3.95
Revenue / Employee
$328.00K
Employees
229
Market Cap
257.55M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202579.59M30.38M61.72%
Dec 31, 202449.22M40.02M435.37%
Dec 31, 20239.19M-16.53M-64.26%
Dec 31, 202225.72M-12.87M-33.35%
Dec 31, 202138.60M-20.97M-35.20%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE174.66M
Genfit65.43M
MedinCell32.44M
Innate Pharma9.01M
Transgene7.21M
Sensorion5.81M
MaaT Pharma4.52M
ABIONYX Pharma4.10M
Revenue Rankings